Assembly Biosciences (ASMB) Preferred Shares (2013)

Assembly Biosciences' (ASMB) quarterly Preferred Shares came in at $44.0 in Q4 2013, down 80.0% quarter-over-quarter from $220.0 in Q3 2013.

Assembly Biosciences (ASMB) Preferred Shares (2013) Analysis & Trends

Assembly Biosciences' Preferred Shares history runs 1 years deep, the most recent figure standing at $44.0 for Q4 2013.

On a quarterly basis, Preferred Shares changed N/A year-over-year to $44.0 in Q4 2013; TTM through Dec 2013 was $44.0, a N/A change from a year earlier, with the FY2013 full-year figure at $44.0, changed N/A from the prior year.
Preferred Shares declined to $44.0 in Q4 2013 per ASMB's latest filing, from $220.0 in the prior quarter.
Across five years, Preferred Shares topped out at $220.0 in Q1 2013 and bottomed at $44.0 in Q4 2013.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Preferred Shares (Qtr)
1	Oculis Holding AG	68,785.72 Bn	68,785.72 Bn	-	-
2	Nanobiotix	1,895.57 Bn	1,895.51 Bn	-	-
3	BeOne Medicines	471.35 Bn	466.56 Bn	1.35 Bn	-
4	NuCana	279.75 Bn	279.75 Bn	-	-
5	Vertex Pharmaceuticals	120.24 Bn	113.00 Bn	2.59 Bn	-
6	Regeneron Pharmaceuticals	67.80 Bn	59.04 Bn	3.31 Bn	-
7	Belite Bio	62.51 Bn	62.51 Bn	-	-
8	Argenx Se	57.38 Bn	57.38 Bn	1.41 Bn	-
9	Revolution Medicines	37.78 Bn	37.78 Bn	-	-
10	Assembly Biosciences	282.74 Mn	56.14 Mn	-	-

Download Data